MRI Assessment of Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease

Magnetic Resonance in Medicine

Volumn 51, Issue 4, 2004, Pages 794-798

  Helpern, Joseph A ^a,b   Lee, Sang Pil ^a   Falangola, Maria F ^a,b   Dyakin, Victor V ^a   Bogart, Adam ^a   Ardekani, Babak ^a,b   Duff, Karen ^a,b   Branch, Craig ^a,c   Wisniewski, Thomas ^a,b   De Leon, Mony J ^a,b   Wolf, Oliver ^d   O'Shea, Jacqueline ^a   Nixon, Ralph A ^a,b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; MRI; Transgenic mice; amyloid

Indexed keywords

BRAIN; CYTOLOGY; DEPOSITION; GENES; GLYCOPROTEINS; MAGNETIC RESONANCE IMAGING; MAMMALS; PEPTIDES; RELAXATION TIME;

ALZHEIMER'S DISEASE; AMYLOID PRECURSOR PROTEINS; AMYLOID-BETA PEPTIDES; CLINICAL SYMPTOMS; NON-INVASIVE DETECTION; RETROSPLENIAL CORTEX; TRANSGENIC MICE; TRANSVERSE RELAXATION TIME;

NEURODEGENERATIVE DISEASES;

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; GENE PRODUCT; PRESENILIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS CALLOSUM; HIPPOCAMPUS; MOUSE; MUTANT; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; SYMPTOMATOLOGY; TRANSGENIC MOUSE;

EID: 12144291398     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20038     Document Type: Article

References (22)

1. Morris JC, Storandt M, McKeel DW Jr, Rubin EH, Price JL, Grant EA, Berg L. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46:707-719.
2. Cataldo A, Peterhoff C, Troncoso J, Gomez-Isla T, Hyman B, Nixon R. Endocytic pathway abnormalities precede beta-amyloid deposition in sporadic Alzheimer's disease: differential effects of APOE genotype and presenilin mutations. Am J Pathol 2000;157:277-286.
3. Haroutunian V, Perl DP, Purohit DP, Marin D, Khan K, Lantz M, Davis KL, Mohs RC. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease [see Comments]. Arch Neurol 1998;55:1185-1191.
4. de Leon MJ, Golomb J, George AE, Convit A, Tarshish CY, McRae T, De Santi S, Smith G, Ferris SH, Noz M. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol 1993;14:897-906.
5. Xu Y, Jack CR Jr, O'Brien PC, Kokmen E, Smith GE, Ivnik RJ, Boeve BF, Tangalos RG, Petersen RC. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 2000;54:1760-1767.
6. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 1996;383:710-713.
7. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 1998; 4:97-100.
8. McGowan E, Sanders S, Iwatsubo T, Takeuchi A, Saido T, Zehr C, Yu X, Uljon S, Wang R, Mann D, Dickson D, Duff K. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol Dis 1999;6:231-244.
9. Takeuchi A, Irizarry MC, Duff K, Saido TC, Hsiao Ashe K, Hasegawa M, Mann DM, Hyman BT, Iwatsubo T. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am J Pathol 2000;157:331-339.
10. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice [see Comments]. Science 1996;274:99-102.
11. Labadie C, Lee JH, Vetek G, Springer CS Jr. Relaxographic imaging. J Magn Reson B 1994;105:99-112.
12. Strupp JP. Stimulate: a GUI based fMRI analysis software package. NeuroImage 1996;3:S607.
13. 1 determination from inversion recovery images: application to human brain at 4 T. Magn Reson Med 1994;31:445-449.
14. Wengenack TM, Whelan S, Curran GL, Duff KE, Poduslo JF. Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain. Neuroscience 2000;101:939-944.
15. Grohn OH, Kettunen MI, Penttonen M, Oja JM, van Zijl PC, Kauppinen RA. Graded reduction of cerebral blood flow in rat as detected by the nuclear magnetic resonance relaxation time T2: a theoretical and experimental approach. J Cereb Blood Flow Metab 2000;20:316-326.
16. Niwa K, Kazama K, Younkin SG, Carlson GA, Iadecola C. Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis 2002;9:61-68.
17. Kurt MA, Davies DC, Kidd M, Duff K, Rolph SC, Jennings KH, Howlett DR. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Exp Neurol 2001;171:59-71.
18. Bartzokis G, Sultzer D, Cummings J, Holt LE, Hance DB, Henderson VW, Mintz J. In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch Gen Psychiatry 2000;57:47-53.
19. Smith MA, Harris PL, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 1997;94:9866-9868.
20. O'Shea JM, Williams SR, van Bruggen N, Gardner-Medwin AR. Apparent diffusion coefficient and MR relaxation during osmotic manipulation in isolated turtle cerebellum. Magn Reson Med 2000;44:427-432.
21. Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, Nixon RA. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci 1996;16:186-199.
22. Nixon R, Mathews P, Cataldo A, Mohan P, Schmidt S, Duff K, Berg M, Marks N, Peterhoff C, Sershen H. In vivo perturbation of lysosomal function promotes neurodegeneration in the PS1M146V/APPK670N,M671L mouse model of Alzheimer's disease pathology, In: Iqbal K, Sisodia S, Winblad B, editors. Alzheimer's disease: advances in etiology, pathogenesis and therapeutics. London: John Wiley & Sons; 2001.